Involvement of tumour necrosis factor-α in Clostridium perfringens β-toxin-induced plasma extravasation in mice

British Journal of Pharmacology

Volumn 153, Issue 6, 2008, Pages 1296-1302

  Nagahama, M ^a   Kihara, A ^a   Kintoh, H ^a   Oda, M ^a   Sakurai, J ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Beta toxin; Clostridium perfringens; Plasma extravasation; Tachykinin NK 1 receptor; TNF

Indexed keywords

CAPSAICIN; CHLORPROMAZINE; CLOSTRIDIUM TOXIN; CYTOKINE; INTERLEUKIN 6; NOLPITANTIUM; PENTOXIFYLLINE; TACHYKININ RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PLASMA; RECEPTORS, NEUROKININ-1; SKIN; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949124780     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.9     Document Type: Article

References (35)

1. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M et al. (2000). Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164: 3471-3475.
2. Alber G, Scheuber PH, Reck B, Sailer-Kramer B, Hartmann A, Hammer DK (1989). Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J Allergy Clin Immunol 84: 880-885.
3. Ansel JC, Armstrong CA, Song I, Quinlan KL, Olerud JE, Caughman SW et al. (1997). Interactions of the skin and nervous system. J Invest Dermatol Symp Proc 2: 23-26.
4. Beutler B (2004). Inferences, questions and possibilities in toll-like receptor signalling. Nature 430: 257-263.
5. Chaves F, Teixeira CFP, Gutiérrez JM (2005). Role of TNF-α, IL-1β and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice. Toxicon 45: 171-178.
6. Gibbs BF, Wierecky J, Welker P, Henz BM, Wolff HH, Grabbe J (2001). Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 10: 312-320.
7. Holzer P (1998). Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30: 5-11.
8. Ishida H, Fujii E, Irie K, Yoshioka T, Muraki T, Ogawa R (2000). Role of inflammatory mediators in lipid A analogue (ONO-4007)-induced vascular permeability change in mouse skin. Br J Pharmacol 130: 1235-1240.
9. Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ (2006). Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol 169: 1713-1721.
10. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y (1989). Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 142: 927-931.
11. McCurdy JD, Lin TJ, Marshall JS (2001). Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70: 977-984.
12. McInturff JE, Modlin RL, Kim J (2005). The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125: 1-8.
13. Murakawa M, Yamaoka K, Tanaka Y, Fukuda Y (2006). Involvement of tumor necrosis factor (TNF)-α in phorbol ester 12-O-tetradecanoylphorbol- 13-acetate (TPA)-induced skin edema in mice. Biochem Pharmacol 71: 1331-1336.
14. Nagahama M, Hayashi S, Morimitstu S, Sakurai J (2003a). Biological activities and pore formation of Clostridium perfringens beta-toxin in HL 60 cells. J Biol Chem 278: 36934-36941.
15. Nagahama M, Kihara A, Miyawaki T, Mukai M, Sakaguchi Y, Ochi S et al. (1999). Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity. Biochim Biophys Acta 1454: 97-105.
16. Nagahama M, Kobayashi K, Ochi S, Sakurai J (1991). Enzyme-linked immunosorbent assay for rapid detection of toxins from Clostridium perfringens. FEMS Microbiol Lett 68: 41-44.
17. Nagahama M, Morimitsu S, Kihara A, Akita M, Setsu K, Sakurai J (2003b). Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation. Br J Pharmacol 138: 23-30.
18. Netea MG, Blok WL, Kullberg BJ, Bemelmans M, Vogels MT, Buurman WA et al. (1995). Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 171: 393-399.
19. Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C et al. (1994). Pentoxifylline in vivo downregulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83: 262-267.
20. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M et al. (2000). Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface toll-like receptor 4 expression. J Immunol 164: 3476-3749.
21. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M (2006). Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86: 1309-1379.
22. Sakurai J, Fujii Y (1987). Purification and characterization of Clostridium perfringens beta toxin. Toxicon 25: 1301-1310.
23. Sakurai J, Fujii Y, Dezaki K, Endo K (1984). Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol Immunol 28: 23-31.
24. Sakurai J, Fujii Y, Matsuura M, Endo K (1981). Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol Immunol 25: 423-432.
25. Sakurai J, Nagahama M (2003). Mechanism of action of Clostridium perfringens beta-toxin. Recent Res Dev Infect Immun 1: 433-449.
26. Sakurai J, Nagahama M (2006). Clostridium perfringens beta-toxin: characterization and action. Toxin Rev 25: 89-108.
27. Sakurai J, Nagahama M, Ochi S (1997). Major toxins of Clostridium perfringens. J Toxicol Toxin Rev 16: 195-214.
28. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK (2000). Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect Immun 68: 5546-5551.
29. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N et al. (2002). Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 119: 424-432.
30. Songer JG (1996). Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 9: 216-234.
31. Steinhoff M, Stander S, Seeliger S, Ansel JC, Schmelz M, Luger T (2003). Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139: 1479-1488.
32. Suganuma T, Irie K, Fujii E, Yoshioka T, Muraki T (2002). Effect of heat stress on lipopolysaccharide-induced vascular permeability change in mice. J Pharmacol Exp Ther 303: 656-663.
33. Tweten RK (2001). Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol 82: 1-9.
34. Wada K, Fujii E, Ishida H, Yoshioka T, Muraki T (2000). Effect of lipoteichoic acid on dermal vascular permeability in mice. J Pharmacol Exp Ther 294: 280-286.
35. Yano H, Wershil BK, Arizono N, Galli SJ (1989). Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84: 1276-1286.